Pulmonary embolism

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The incidence and mortality of acute pulmonary embolism (PE) remain ill defined, particularly in the setting of the emergency department. However, high-risk groups can be identified based on medical conditions known to predispose patients to venous thrombosis. Recent research into the physiologic regulation of coagulation and thrombolysis reveals that recurrent venous thrombosis and PE may be caused by heritable deficiencies and abnormalities of plasma proteins. To decide among options for evaluation and treatment of patients suspected of PE, physicians combine clinical assessment with patterns observed on radionuclide ventilation-perfusion (V/Q) scans. However, the prevalence of PE among patients with "low probability" V/Q scans suggests that current physician behavior may be imprudent. Heparin anticoagulation continues to be standard therapy for acute PE, but newer clot-specific thrombolytic drugs may offer superior benefits with acceptable complication rates in carefully selected patients.

Original languageEnglish (US)
Pages (from-to)209-213
Number of pages5
JournalAnnals of Emergency Medicine
Volume17
Issue number3
DOIs
StatePublished - 1988

Fingerprint

Pulmonary Embolism
Venous Thrombosis
Physicians
Fibrinolytic Agents
Radioisotopes
Ventilation
Heparin
Hospital Emergency Service
Blood Proteins
Perfusion
Mortality
Incidence
Therapeutics
Research

Keywords

  • pulmonary embolism

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Pulmonary embolism. / Valenzuela, Terence D.

In: Annals of Emergency Medicine, Vol. 17, No. 3, 1988, p. 209-213.

Research output: Contribution to journalArticle

Valenzuela, Terence D. / Pulmonary embolism. In: Annals of Emergency Medicine. 1988 ; Vol. 17, No. 3. pp. 209-213.
@article{13303a2b8d914a81b318a2dea5440a94,
title = "Pulmonary embolism",
abstract = "The incidence and mortality of acute pulmonary embolism (PE) remain ill defined, particularly in the setting of the emergency department. However, high-risk groups can be identified based on medical conditions known to predispose patients to venous thrombosis. Recent research into the physiologic regulation of coagulation and thrombolysis reveals that recurrent venous thrombosis and PE may be caused by heritable deficiencies and abnormalities of plasma proteins. To decide among options for evaluation and treatment of patients suspected of PE, physicians combine clinical assessment with patterns observed on radionuclide ventilation-perfusion (V/Q) scans. However, the prevalence of PE among patients with {"}low probability{"} V/Q scans suggests that current physician behavior may be imprudent. Heparin anticoagulation continues to be standard therapy for acute PE, but newer clot-specific thrombolytic drugs may offer superior benefits with acceptable complication rates in carefully selected patients.",
keywords = "pulmonary embolism",
author = "Valenzuela, {Terence D}",
year = "1988",
doi = "10.1016/S0196-0644(88)80108-2",
language = "English (US)",
volume = "17",
pages = "209--213",
journal = "Annals of Emergency Medicine",
issn = "0196-0644",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Pulmonary embolism

AU - Valenzuela, Terence D

PY - 1988

Y1 - 1988

N2 - The incidence and mortality of acute pulmonary embolism (PE) remain ill defined, particularly in the setting of the emergency department. However, high-risk groups can be identified based on medical conditions known to predispose patients to venous thrombosis. Recent research into the physiologic regulation of coagulation and thrombolysis reveals that recurrent venous thrombosis and PE may be caused by heritable deficiencies and abnormalities of plasma proteins. To decide among options for evaluation and treatment of patients suspected of PE, physicians combine clinical assessment with patterns observed on radionuclide ventilation-perfusion (V/Q) scans. However, the prevalence of PE among patients with "low probability" V/Q scans suggests that current physician behavior may be imprudent. Heparin anticoagulation continues to be standard therapy for acute PE, but newer clot-specific thrombolytic drugs may offer superior benefits with acceptable complication rates in carefully selected patients.

AB - The incidence and mortality of acute pulmonary embolism (PE) remain ill defined, particularly in the setting of the emergency department. However, high-risk groups can be identified based on medical conditions known to predispose patients to venous thrombosis. Recent research into the physiologic regulation of coagulation and thrombolysis reveals that recurrent venous thrombosis and PE may be caused by heritable deficiencies and abnormalities of plasma proteins. To decide among options for evaluation and treatment of patients suspected of PE, physicians combine clinical assessment with patterns observed on radionuclide ventilation-perfusion (V/Q) scans. However, the prevalence of PE among patients with "low probability" V/Q scans suggests that current physician behavior may be imprudent. Heparin anticoagulation continues to be standard therapy for acute PE, but newer clot-specific thrombolytic drugs may offer superior benefits with acceptable complication rates in carefully selected patients.

KW - pulmonary embolism

UR - http://www.scopus.com/inward/record.url?scp=0023865467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023865467&partnerID=8YFLogxK

U2 - 10.1016/S0196-0644(88)80108-2

DO - 10.1016/S0196-0644(88)80108-2

M3 - Article

C2 - 3278657

AN - SCOPUS:0023865467

VL - 17

SP - 209

EP - 213

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

SN - 0196-0644

IS - 3

ER -